Low-intensity warfarin therapy for anticoagulation in atrial fibrillation patients with high risk of hemorrhage: a clinical trial on efficiency and safety
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To determine the safety and availability of anticoagulation of low-intensity warfarin therapy in atrial fibrillation (AF) patients with high risk of stroke and bleeding applying stroke risk score (CHA2DS2-VASc) and bleeding risk score (HAS-BLED) (CHA2DS2-VASc≥1 and HAS-BLED≥3) proposed by 2010 European Society of Cardiology Guideline. Methods A total of 99 AF patients who had the stroke risk scoring CHA2DS2-VASc≥1 and HAS-BLED score≥3 admitted in our hospital from January 2011 to January 2012 were selected randomly, and then divided into 2 groups. One group was treated by a standard intensity warfarin therapy of 2.0<International Normalized Ratio (INR)≤3.0, and the other group was given a low-intensity warfarin therapy (1.6≤INR≤2.0). The incidence of stroke and bleeding events of the two groups were compared. Results Chi-square test indicated that there was no statistical difference in the incidence of stroke and bleeding between these 2 groups (P>0.05). The incidence of bleeding was significantly higher in standard-intensity Warfarin group than in low-intensity Warfarin group (P<0.05). Conclusion AF patients with high bleeding risk (CHA2DS2-VASc≥1 and HAS-BLED score≥3) should be treated by low-intensity warfarin anticoagulation. The therapy is safe and reliable, with advantages of suppressing thrombosis and embolism events and not increasing serious hemorrhage.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: January 22,2014
  • Published:
Article QR Code